Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 76420-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 76420-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Relabel (Cyclobenzaprine HCl Tabs 5mg Label 1)

Relabel (Cyclobenzaprine HCl Tabs 5mg Label 1)
This is a list of packaged Cyelobenzaprine HCI Tablets, USP 5mg in different quantities (30, 60, 90, 100, and 120) by TruPharma, LLC, each with a unique NDC and batch number. The tablets are yellow, round, and film-coated. They are prescription-only drugs and should be stored out of reach of children at 20-25°C. Federal laws prohibit dispensing without a prescription.*
FDA Label Image

Repack (Cyclobenzaprine HCl Tabs 5mg Label 2)

Repack (Cyclobenzaprine HCl Tabs 5mg Label 2)
This is a label of Cyclobenzaprine HCI Tablets of strength 5mg, with a quantity of 500. The tablets are distributed by TruPhamma, LLC and the source NDC is 52817-330-50. The tablets are categorized as RX drug and cannot be sold without a prescription. The lot number for these tablets is 00000000 B. The description mentions the color, shape, and markings on the tablets. The label also contains cautionary information suggesting the storage and handling instructions.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.